Pfizer’s Strategic Gambit: A $7.3 Billion Entry into the Weight-Loss Arena
In a move signaling its serious intent to capture a share of the lucrative anti-obesity drug market, US pharmaceutical titan ...
Tag: Pfizer
Pfizer’s Strategic Pivot: Seeking External Partner for Promising Cancer Drug
In a notable strategic shift, Pfizer and its collaborator Arvinas have announced they will seek an external commercialization partner for ...
Navigating Political Headwinds and Pipeline Setbacks: Pfizer’s Strategic Pivot
Pfizer finds itself navigating increasingly turbulent political waters as it works to reduce its reliance on COVID-related products. Simultaneous regulatory ...
Pfizer’s Vaccine Breakthrough: A Turning Point for the Struggling Stock?
Pharmaceutical giants Pfizer and BioNTech have announced positive clinical trial results for their updated COVID-19 vaccine, timed to coincide with ...
Pfizer’s Narrow Vaccine Approval Presents Commercial Challenge
Pfizer has secured a critical regulatory milestone, receiving FDA approval for its updated COVID-19 vaccine, COMIRNATY LP.8.1. However, the triumph ...
Pfizer Stock: Morgan Stanley Raises Target Amid Strong Earnings
Pfizer’s stock received a boost as Morgan Stanley raised its price target from $32 to $33, reflecting optimism after the ...
Pfizer Stock: Legal Woes and Political Pressure Mount
A UK appeals court dealt a significant blow to Pfizer by upholding Moderna's key mRNA technology patent (EP'949) and confirming ...
Don't Miss It
Popular News
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
-
NextGen Healthcare Charts Course for Behavioral Health Transformation
-
Regulatory Shift Sparks Potential Breakthrough for DeFi Technologies
